Sandoz Tacrolimus capsules

Tacrolimus is a potent immunosuppressive medication primarily used to prevent organ rejection in transplant patients. This specific pharmaceutical product is a generic version of the drug, manufactured under the branding of Sandoz. The history of Tacrolimus dates back to its discovery in 1987 in Japan by the Fujisawa Pharmaceutical Co. (now part of Astellas Pharma).

Today, the brand shown is Sandoz, which is a global leader in generic pharmaceuticals and biosimilars. Sandoz was originally founded in Basel, Switzerland, and for many decades operated as a division of the Swiss multinational Novartis. However, in late 2023, Sandoz transitioned into a standalone, publicly traded company. Production of generic medications like Tacrolimus occurs across a vast global network of facilities, including sites in Europe, Asia, and North America, ensuring the product is available in various international markets.